Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients
Clinical trial NCT02943473 · TERMINATED
Trial details
- NCT number
- NCT02943473
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-18
- Primary completion
- 2019-09-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.